|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for RPN2 |
Basic gene info. | Gene symbol | RPN2 |
Gene name | ribophorin II | |
Synonyms | RIBIIR|RPN-II|RPNII|SWP1 | |
Cytomap | UCSC genome browser: 20q12-q13.1 | |
Genomic location | chr20 :35807455-35870025 | |
Type of gene | protein-coding | |
RefGenes | NM_001135771.1, NM_002951.3, | |
Ensembl id | ENSG00000118705 | |
Description | dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunitdolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2oligosaccharyltransferase complex subunit (non-catalytic)ribophorin-2 | |
Modification date | 20141222 | |
dbXrefs | MIM : 180490 | |
HGNC : HGNC | ||
Ensembl : ENSG00000118705 | ||
HPRD : 01609 | ||
Vega : OTTHUMG00000032409 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_RPN2 | |
BioGPS: 6185 | ||
Gene Expression Atlas: ENSG00000118705 | ||
The Human Protein Atlas: ENSG00000118705 | ||
Pathway | NCI Pathway Interaction Database: RPN2 | |
KEGG: RPN2 | ||
REACTOME: RPN2 | ||
ConsensusPathDB | ||
Pathway Commons: RPN2 | ||
Metabolism | MetaCyc: RPN2 | |
HUMANCyc: RPN2 | ||
Regulation | Ensembl's Regulation: ENSG00000118705 | |
miRBase: chr20 :35,807,455-35,870,025 | ||
TargetScan: NM_001135771 | ||
cisRED: ENSG00000118705 | ||
Context | iHOP: RPN2 | |
cancer metabolism search in PubMed: RPN2 | ||
UCL Cancer Institute: RPN2 | ||
Assigned class in ccmGDB | C |
Top |
Phenotypic Information for RPN2(metabolism pathway, cancer, disease, phenome) |
![]() | |
Cancer | CGAP: RPN2 |
Familial Cancer Database: RPN2 |
* This gene is included in those cancer gene databases. |
. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
![]() | |
REACTOME_METABOLISM_OF_PROTEINS |
![]() | |
OMIM | |
Orphanet | |
Disease | KEGG Disease: RPN2 |
MedGen: RPN2 (Human Medical Genetics with Condition) | |
ClinVar: RPN2 | |
Phenotype | MGI: RPN2 (International Mouse Phenotyping Consortium) |
PhenomicDB: RPN2 |
Mutations for RPN2 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
![]() |
- Statistics for Tissue and Mutation type | Top |
![]() |
- For Inter-chromosomal Variations |
There's no inter-chromosomal structural variation. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
![]() |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
pancreas | RPN2 | chr20 | 35819010 | 35819030 | RPN2 | chr20 | 35822245 | 35822265 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
![]() |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows RPN2 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
CF125171 | RPN2 | 1 | 104 | 20 | 35835739 | 35835842 | MED15 | 97 | 666 | 22 | 20861958 | 20918847 | |
AA740310 | GPX3 | 1 | 227 | 5 | 150408293 | 150408522 | RPN2 | 219 | 437 | 20 | 35812585 | 35826827 | |
BC009430 | GAPDH | 61 | 997 | 12 | 6646122 | 6647537 | RPN2 | 997 | 1744 | 20 | 35857110 | 35870026 | |
AA367913 | C5orf42 | 1 | 105 | 5 | 37201714 | 37201819 | RPN2 | 105 | 339 | 20 | 35812749 | 35827562 | |
BE075537 | RPN2 | 13 | 481 | 20 | 35842162 | 35857107 | RPN2 | 482 | 606 | 20 | 35833209 | 35835703 | |
BI051087 | RPN2 | 6 | 90 | 20 | 35826836 | 35827477 | RPN2 | 86 | 323 | 20 | 35833177 | 35835785 | |
BG390108 | RPN2 | 15 | 66 | 20 | 35857081 | 35857132 | RPN2 | 62 | 483 | 20 | 35857114 | 35869832 |
![]() |
Top |
![]() |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample | 3 |   |   | 1 |   |   | 2 |   |   |   |   |   |   |   |   |   |   | |||
GAIN (# sample) | 3 |   |   | 1 |   |   | 2 |   |   |   |   |   |   |   |   |   |   | |||
LOSS (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
![]() |
|
![]() |
Top |
![]() |
Stat. for Non-Synonymous SNVs (# total SNVs=34) | (# total SNVs=16) |
![]() | ![]() |
(# total SNVs=0) | (# total SNVs=0) |
Top |
![]() |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr20:35827443-35827443 | p.? | 3 |
chr20:35835810-35835810 | p.P275P | 2 |
chr20:35833268-35833268 | p.L218L | 2 |
chr20:35865068-35865068 | p.T613T | 2 |
chr20:35835736-35835736 | p.E251K | 2 |
chr20:35862445-35862445 | p.V567A | 2 |
chr20:35862446-35862446 | p.V567V | 2 |
chr20:35826803-35826803 | p.A71S | 1 |
chr20:35852284-35852284 | p.R366G | 1 |
chr20:35832307-35832307 | p.T167A | 1 |
Top |
![]() |
|
![]() |
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 1 |   |   | 10 | 2 |   | 1 |   | 4 |   |   | 5 |   | 3 |   |   | 8 | 4 |   | 6 |
# mutation | 1 |   |   | 10 | 2 |   | 1 |   | 4 |   |   | 6 |   | 3 |   |   | 8 | 4 |   | 6 |
nonsynonymous SNV |   |   |   | 6 |   |   |   |   | 2 |   |   | 4 |   | 2 |   |   | 2 | 3 |   | 5 |
synonymous SNV | 1 |   |   | 4 | 2 |   | 1 |   | 2 |   |   | 2 |   | 1 |   |   | 6 | 1 |   | 1 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
![]() |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr20:35862445 | p.V535A,RPN2 | 2 |
chr20:35862446 | p.V535V,RPN2 | 2 |
chr20:35856957 | p.F382F,RPN2 | 1 |
chr20:35827572 | p.T581T,RPN2 | 1 |
chr20:35862467 | p.A143G,RPN2 | 1 |
chr20:35835810 | p.A157A,RPN2 | 1 |
chr20:35857024 | p.F403S,RPN2 | 1 |
chr20:35827584 | p.V594V,RPN2 | 1 |
chr20:35862471 | p.R158S,RPN2 | 1 |
chr20:35838528 | p.N425N,RPN2 | 1 |
![]() |
![]() |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
![]() |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for RPN2 |
![]() |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
![]() |
![]() |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
![]() |
Top |
![]() |
* This plots show the correlation between CNV and gene expression. |
![]() | |
![]() |
Top |
Gene-Gene Network Information |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
![]() | |||||
ACTR5,BLCAP,C20orf24,NDUFAF5,CTNNBL1,ESF1,TTI1, LOC100130274,MANBAL,MKKS,NDRG3,RALGAPB,RBL1,RPN2, RPRD1B,SNHG11,SNRPB2,SRC,SRXN1,TOMM34,YWHAB | AGA,C14orf1,ABRACL,DAP,DPAGT1,GSS,HSPA5, MYCBP,PDIA3,PDIA3P1,PDIA6,PRDX1,SLC50A1,RNPEP, RPN1,RPN2,SLC35A2,SRPRB,TM9SF1,TMED3,YIPF1 | ||||
![]() | |||||
AAR2,RTFDC1,CTNNBL1,DHX35,EIF2S2,ERGIC3,MTG2, HM13,TTI1,MAPRE1,NFS1,PIGU,RALY,RPN2, RPRD1B,STAU1,NELFCD,TP53RK,TRPC4AP,UQCC1,YTHDF1 | CCNE1,COPB2,CRELD2,DNAJB11,GINS4,GMPPB,HM13, HSP90B1,HSPA5,HYOU1,LRRC59,MCM10,PDIA3,PDIA3P1, PDIA4,RPN2,RRM2,SEC23B,SEC61A1,SSR1,STT3A |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
![]() |
Top |
Pharmacological Information for RPN2 |
![]() |
DB Category | DB Name | DB's ID and Url link |
![]() |
* Gene Centered Interaction Network. |
![]() |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB01248 | ribophorin II | approved; investigational | Docetaxel | ![]() | ![]() |
DB00171 | ribophorin II | approved; nutraceutical | Adenosine triphosphate | ![]() | ![]() |
Top |
Cross referenced IDs for RPN2 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |